from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2476c/gdh

LFCtreatmentdescriptionclass of inhibitor

-1.433

Amikacinug/mL Amikacintranslation

-3.021

Cap5-10ug/mL Capreomycintranslation

-3.692

Rox10-50 ug/mL Roxithromycintranslation

-0.481

SM2-5 ug/mL Streptomycintranslation

-3.983

Tet5-10 ug/mL Tetracyclinetranslation

0.001

Rif0.2-5ug/mL Rifampicintranscription

-1.164

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.214

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.236

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.667

CPZ10-50 ug/mL Chlorpromazinerespiration

0.796

Clofazimine10-13 ug/mL Clofaziminerespiration

0.748

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.692

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.270

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.035

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.133

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.402

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.720

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.214

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.277

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.203

KCN5-20 ug/mL Potassium cyaniderespiration

1.461

NaN30.2-2 mM Sodium aziderespiration

0.598

Nigericin50 uM Nigericinrespiration

-0.073

TRC10-150 ug/mL Triclosanrespiration

-0.404

TRZ10-25 ug/mL Thioridazinerespiration

-2.843

Valinomycin0.5-10 uM Valinomycinrespiration

0.587

ZnSO42 mM ZnSO4respiration

-0.644

menadione6-10 ug/mL Menadionerespiration

0.033

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.328

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.031

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.580

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.304

NRP_1Non-replicating persistence stage 1dosRassociated

0.426

Amp0.2mg/mL AmpicillincellWall

0.251

Cephalexin20-100 ug/mL CephalexincellWall

0.036

Cerulenin0.32-5 ug/mL CerulenincellWall

0.173

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.069

EMB10-20 ug/mL EthambutolcellWall

0.523

Eta12-40 ug/mL EthionamidecellWall

0.172

INH0.2-0.4 ug/mL IsoniazidcellWall

0.469

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.169

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.029

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.332

BZA0.12 mg/mL BenzamidearomaticAmides

-0.166

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.411

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.109

H2O24 mM hydrogen peroxideDNAdamaging

0.253

Levo10 ug/mL LevofloxacinDNAdamaging

0.417

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.721

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.098

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.549

UVUV-irradiationDNAdamaging

-1.120

ARP41-4 ug/mL Antitubercular compound ARP4?

0.500

Antimycin12.5-50 ug/mL Antimycin A?

0.272

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.120

PA_110-50 ug/mL Antitubercular compound PA-1?

1.020

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.265

PA8240.2-2 ug/mL PA-824?

-0.106

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.436

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.539

Verapamil50 uM Verapamil?

0.389

mercaptoethanol2 mM 2-Mercaptoethanol?

0.629

methoxatin10-20 ug/mL Methoxatin?